Matches in Wikidata for { <http://www.wikidata.org/entity/Q92805785> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q92805785 description "article scientifique publié en 2020" @default.
- Q92805785 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92805785 description "bài báo khoa học" @default.
- Q92805785 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92805785 description "scientific article published on 21 January 2020" @default.
- Q92805785 description "wetenschappelijk artikel" @default.
- Q92805785 description "наукова стаття, опублікована 21 січня 2020" @default.
- Q92805785 name "Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects" @default.
- Q92805785 name "Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects" @default.
- Q92805785 type Item @default.
- Q92805785 label "Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects" @default.
- Q92805785 label "Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects" @default.
- Q92805785 prefLabel "Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects" @default.
- Q92805785 prefLabel "Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects" @default.
- Q92805785 P1433 Q92805785-60BA8878-3D7F-4D0E-B109-59A63A645E92 @default.
- Q92805785 P1476 Q92805785-AD701890-097D-4A29-A656-257FA0D06779 @default.
- Q92805785 P2093 Q92805785-320E1137-A2EF-4BFF-9B26-FE684E01289E @default.
- Q92805785 P2093 Q92805785-4953959D-6B23-47BA-A18C-A6739B84BD89 @default.
- Q92805785 P2093 Q92805785-8EFAB8D5-BB35-403E-A705-A6E64DF31CAA @default.
- Q92805785 P2093 Q92805785-9C0F40ED-8574-4F0E-B073-FFF628DA19B6 @default.
- Q92805785 P2093 Q92805785-BDBC7A56-E7D3-4CDC-8734-8F2523E6C60D @default.
- Q92805785 P2093 Q92805785-C58B03D9-E3B0-4C51-8E1F-479F5822EEE8 @default.
- Q92805785 P304 Q92805785-3BFB7667-A6AF-436A-8DCE-334D553E392F @default.
- Q92805785 P31 Q92805785-D90DC6A7-D1A2-4B77-ADCA-C1DAE41141D5 @default.
- Q92805785 P356 Q92805785-EB526A9E-B17B-43D9-9DE1-7D7FDE972B3F @default.
- Q92805785 P433 Q92805785-7F086883-C28C-49AC-930B-3CF75BF72842 @default.
- Q92805785 P478 Q92805785-677CB380-E1A1-40E5-AD22-726612D1C4FB @default.
- Q92805785 P50 Q92805785-D0F1D5FD-4A0F-4558-BFBB-ED1F671CD936 @default.
- Q92805785 P577 Q92805785-30E4A97F-0694-48AE-98F4-A4310678064A @default.
- Q92805785 P698 Q92805785-2F69AFB2-5EB8-4748-B305-DEF592828CD0 @default.
- Q92805785 P356 HAE.13930 @default.
- Q92805785 P698 31962376 @default.
- Q92805785 P1433 Q15753375 @default.
- Q92805785 P1476 "Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects" @default.
- Q92805785 P2093 "Elysse Dean" @default.
- Q92805785 P2093 "Grace Gilmore" @default.
- Q92805785 P2093 "Roslyn Bonar" @default.
- Q92805785 P2093 "Ross Baker" @default.
- Q92805785 P2093 "Sandya Arunachalam" @default.
- Q92805785 P2093 "Soma Mohammed" @default.
- Q92805785 P304 "354-362" @default.
- Q92805785 P31 Q13442814 @default.
- Q92805785 P356 "10.1111/HAE.13930" @default.
- Q92805785 P433 "2" @default.
- Q92805785 P478 "26" @default.
- Q92805785 P50 Q88048022 @default.
- Q92805785 P577 "2020-01-21T00:00:00Z" @default.
- Q92805785 P698 "31962376" @default.